Safety, tolerability and treatment effectiveness of chronic hepatitis B patients with pradefovir: a phase 1b multiple ascending dose study

被引：0
|
作者：
Jingrui, L. [1 ]
Junqi, N. [1 ]
Yanhua, D. [1 ]
Ning, X. [2 ]
Xiaoxue, Z. [1 ]
Xiaojiao, L. [1 ]
机构：
[1] Jilin Univ, Hosp 1, Changchun, Peoples R China
[2] Jilin Univ, Hosp 4, Changchun, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30471-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LBP-526
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] Phase 1b single and multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of HT-100 in DMD
    Escolar, D. M.
    Davis-Golden, J.
    Loewy, J.
    Bush, E.
    Dykstra, K.
    Blaustein, M.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 802 - 803
  • [2] Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection
    Zhang, Hong
    Wu, Min
    Zhu, Xiaoxue
    Li, Cuiyun
    Li, Xiaojiao
    Jin, Weili
    Zhang, Dengke
    Chen, Hong
    Liu, Chengjiao
    Ding, Yanhua
    Niu, Junqi
    Liu, Jingrui
    ANTIVIRAL RESEARCH, 2020, 174
  • [3] Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection:: 48-week analysis of a phase 2 study
    Lee, K. S.
    Lim, S. G.
    Chuang, W. L.
    Hwang, S. G.
    Cho, M.
    Lai, M. Y.
    Chao, Y. C.
    Chang, T. T.
    Han, K. H.
    Lee, C. M.
    Um, S. H.
    Yeon, J. E.
    Yang, S. S.
    Teo, E. K.
    Peng, C. Y.
    Lin, H. H.
    Yang, S. S.
    Huo, T. I.
    Nguyen, T.
    Chen, T. Y.
    Hu, K. Q.
    Xu, Y.
    Sullivan-Bolyai, J. Z.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S274 - S274
  • [4] Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial
    Kim, Jeongjun
    Choi, Jinho
    Kang, Hwankyu
    Ahn, Jiye
    Hutchings, Jane
    Niekerk, Christo van
    Kim, Jaeseung
    Jeon, Yeejin
    Nam, Kiyean
    Kim, Tae Hwan
    Shin, Beom Soo
    Shin, Soyoung
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (01)
  • [5] Safety, tolerability, antiviral activity, and pharmacokinetics of pradefovir mesylate in patients with chronic hepatitis B virus infection: 24-week interim analysis of a phase 2 study
    Sullivan-Bolyai, J
    Lim, SG
    Lee, KS
    Chuang, WL
    Hwang, SG
    Cho, M
    Lai, MY
    Chao, YC
    Chang, TT
    Xu, Y
    HEPATOLOGY, 2005, 42 (04) : 751A - 751A
  • [6] Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy
    Hong, Thomas
    Chang, Andrew
    Maddess, Ted
    Provis, Jan
    Penfold, Philip
    BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [7] A phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographic atrophy
    Hong, Thomas
    Chang, Andrew
    Maddess, Ted
    Provis, Jan
    Penfold, Philip
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (08): : 955 - 955
  • [8] A NOVEL ORAL FORMULATION OF FENRETINIDE DEMONSTRATES SAFETY AND TOLERABILITY IN A PHASE 1B DOSE-ASCENDING TRIAL INVOLVING ADULT CYSTIC FIBROSIS PATIENTS
    Radzioch, D.
    Wojewodka, G.
    Cupri, S.
    Colin, P.
    Pislariu, R.
    Garic, D.
    Kianicka, I
    Matouk, E.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 290 - 290
  • [9] Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial
    Hernandez, Gerson D.
    Solinsky, Christine M.
    Mack, Wendy J.
    Kono, Naoko
    Rodgers, Kathleen E.
    Wu, Chun-Yi
    Mollo, Ana R.
    Lopez, Claudia M.
    Pawluczyk, Sonia
    Bauer, Gerhard
    Matthews, Dawn
    Shi, Yonggang
    Law, Meng
    Rogawski, Michael A.
    Schneider, Lon S.
    Brinton, Roberta D.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)
  • [10] A PHASE 1B, OPEN- LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HEPATITIS B VIRUS COMBINATION THERAPIES IN PATIENTS LIVING WITH CHRONIC HEPATITIS B
    Gane, Edward
    Lim, Tien Huey
    Ngu, Jing Hieng
    Tedesco, Dana
    Duan, Ran
    Pan, David
    Botros, Irina
    Shaik, Naveed
    Mateo, Roberto
    Balsitis, Scott
    Wallin, Jeffrey
    Abramov, Frida
    Lau, Audrey
    Wong, Grace
    HEPATOLOGY, 2024, 80 : S258 - S259
12345